FDA Clears Parky App, Device to Monitor Motor Symptoms

The U.S. Food and Drug Administration (FDA) has given h2o therapeutics 510(k) marketing clearance for its Parky app that monitors motor symptoms in Parkinson’s patients via measurements recorded by an Apple Watch. “As a woman-founded, non [venture capital]-backed company based in Turkey, receiving our first 510(k) clearance is…